Co-administration of liraglutide and ghrelin ameliorates brain mitochondrial energy metabolism in the R6/2 mouse model for Huntington's disease

被引：0
|
作者：
Mena, D. [1 ,2 ,3 ]
Alves, M. I. [1 ,2 ,3 ]
Sjogren, M. [4 ]
Silva, D. F. [1 ,2 ]
Oliveira, C. R. [1 ,2 ,5 ]
Moreira, P. I. [1 ,2 ,6 ]
Bjorkqvist, M. [4 ]
Duarte, A. I. [1 ,2 ,7 ]
机构：
[1] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Univ Coimbra, CiBB, Coimbra, Portugal
[3] Univ Coimbra, Fac Med, Coimbra, Portugal
[4] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Brain Dis Biomarker Unit, Lund, Sweden
[5] Univ Coimbra, Fac Med, Biochem Lab, Coimbra, Portugal
[6] Univ Coimbra, Fac Med, Lab Physiol, Coimbra, Portugal
[7] Univ Coimbra, IIIUC Inst Interdisciplinary Res, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2020年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
54ASM-0304
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [21] Quantifying Tremor in the R6/2 Mouse model of Huntington's Disease
    Skelton, H.
    Grogan, D.
    Rubiano, J.
    Gross, R.
    Gutekunst, C.
    MOVEMENT DISORDERS, 2021, 36 : S109 - S109
  • [22] Cardiac dysfunction in the R6/2 mouse model of Huntington's disease
    Mihm, Michael J.
    Amann, Deborah M.
    Schanbacher, Brandon L.
    Altschuld, Ruth A.
    Bauer, John Anthony
    Hoyt, Karl R.
    NEUROBIOLOGY OF DISEASE, 2007, 25 (02) : 297 - 308
  • [23] Brain Diffusivity and Structural Changes in the R6/2 Mouse Model of Huntington Disease
    Vorisek, Ivan
    Syka, Michael
    Vargova, Lydia
    JOURNAL OF NEUROSCIENCE RESEARCH, 2017, 95 (07) : 1474 - 1484
  • [24] Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease
    Perry, Giselle M.
    Tallaksen-Greene, Sara
    Kumar, Ashish
    Heng, Mary Y.
    Kneynsberg, Andrew
    van Groen, Thomas
    Detloff, Peter J.
    Albin, Roger L.
    Lesort, Mathieu
    HUMAN MOLECULAR GENETICS, 2010, 19 (17) : 3354 - 3371
  • [25] Integrative Characterization of the R6/2 Mouse Model of Huntington's Disease Reveals Dysfunctional Astrocyte Metabolism
    Skotte, Niels H.
    Andersen, Jens V.
    Santos, Alberto
    Aldana, Blanca I.
    Willert, Cecilie W.
    Norremolle, Anne
    Waagepetersen, Helle S.
    Nielsen, Michael L.
    CELL REPORTS, 2018, 23 (07): : 2211 - 2224
  • [26] Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's disease
    Phillips, Wendy
    Morton, A. Jennifer
    Barker, Roger A.
    NEUROREPORT, 2006, 17 (15) : 1623 - 1627
  • [27] Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington's disease
    Hashimoto, Masayo
    Watanabe, Kenichi
    Miyoshi, Kan
    Koyanagi, Yukako
    Tadano, Jun
    Miyawaki, Izuru
    FEBS OPEN BIO, 2021, 11 (10): : 2807 - 2818
  • [28] Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington's Disease
    Paldino, Emanuela
    Balducci, Claudia
    La Vitola, Pietro
    Artioli, Luisa
    D'Angelo, Vincenza
    Giampa, Carmela
    Artuso, Vladimiro
    Forloni, Gianluigi
    Fusco, Francesca R.
    MOLECULAR NEUROBIOLOGY, 2020, 57 (04) : 1889 - 1903
  • [29] Disrupted Temporal Control in the R6/2 Mouse Model of Huntington's Disease
    Balci, Fuat
    Day, Mark
    Rooney, Aislinn
    Brunner, Dam
    BEHAVIORAL NEUROSCIENCE, 2009, 123 (06) : 1353 - 1358
  • [30] N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease
    D J Wright
    T Renoir
    Z M Smith
    A E Frazier
    P S Francis
    D R Thorburn
    S L McGee
    A J Hannan
    L J Gray
    Translational Psychiatry, 2015, 5 : e492 - e492
12345